Additional file 5 of Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer

Supplementary Material 5: Additional file 5.xlsx - Summary of variants classified as pathogenic and likely pathogenic: Shows a list of patients and each variant classified as pathogenic or likely pathogenic. The table also includes a column of which variants were found in the broader next-generation sequencing panel.